Cancer Biomarkers & Screening

A malignancy biomarker alludes to a substance or procedure that is characteristic of the nearness of disease in the body. A biomarker might be an atom emitted by a tumor or a particular reaction of the body to the nearness of malignant growth. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for malignancy finding, guess, and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-intrusively gathered biofluids like blood or serum

    Related Conference of Cancer Biomarkers & Screening

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Cancer Biomarkers & Screening Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in